Migraine Prevention News: Peripheral Supraorbital Transcutaneous Stimulation
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The Migraine.com team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
1. Jean Schoenen, MD, PhD; Bart Vandersmissen, MD; Sandrine Jeangette, MD; Luc Herroelen, MD; Michel Vandenheed, MD; Pascale Gérard, Phy; and Delphine Magis, MD, PhD, ” Migraine prevention with a supraorbital transcutaneous stimulator: A randomized controlled trial,” Neurology, Published online before print, Feb. 6, 2013, http://www.neurology.org/content/early/2013/02/06/WNL.0b013e3182825055.abstract, accessed Feb. 5, 2013. 2. Eishi Asano, MD, PhD, MS; and Peter J. Goadsby, MD, PhD; “How do we fashion better trials for neurostimulator studies in migraine?” Neurology, Published online before print, Feb. 6, 2013, http://www.neurology.org/content/early/2013/02/06/WNL.0b013e3182825174.excerpt, accessed Feb. 5, 2013. 3. North American Neuromodulation Society, “About Neuromodulation,” http://www.neuromodulation.org/About-Neuromodulation/About-Neuromodulation/aboutneuromodulation.html, accessed Feb. 5, 2013. 5. Bartleby.com, Gray’s Anatomy of the Human Body: Trigeminal Nerves, http://www.bartleby.com/107/200.html, accessed Feb. 5, 2013.